Pharmaceutical Preparations · DE · CIK 1878313
MAIA Biotechnology develops targeted immunotherapies for cancer, including its lead asset ateganosine
Comparable business profile · signals at a glance
In the 90 days to Dec 22, 2025: 5 insiders bought $539K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 22, 2025 | Louie Ngar YeeDirector | Buy | 81,699 | $1.22 | $100K |
| Dec 22, 2025 | Smith StanDirector | Buy | 57,189 | $1.22 | $70K |
| Dec 22, 2025 | Chaouki Steven MDirector | Buy | 40,849 | $1.22 | $50K |
| Dec 5, 2025 | Smith StanDirector | Buy | 4,580 | $1.20 | $5K |
| Dec 5, 2025 | Smith StanDirector | Buy | 4,580 | $1.19 | $5K |
| Nov 28, 2025 | Vitoc VladChief Executive Officer | Buy | 50,000 | $1.14 | $57K |
| Nov 28, 2025 | Vitoc VladChief Executive Officer | Buy | 50,000 | $1.14 | $57K |
| Nov 28, 2025 | Luput CristianDirector | Buy | 18,145 | $1.11 | $20K |
| Nov 26, 2025 | Vitoc VladChief Executive Officer | Buy | 22,000 | $1.05 | $23K |
| Nov 26, 2025 | Vitoc VladChief Executive Officer | Buy | 22,000 | $1.05 | $23K |
| Nov 26, 2025 | Luput CristianDirector | Buy | 20,000 | $1.08 | $22K |
| Nov 26, 2025 | Smith StanDirector | Buy | 15,000 | $1.04 | $16K |
| Nov 25, 2025 | Smith StanDirector | Buy | 15,000 | $0.98 | $15K |
| Nov 25, 2025 | Vitoc VladChief Executive Officer | Buy | 10,500 | $0.97 | $10K |
| Nov 25, 2025 | Vitoc VladChief Executive Officer | Buy | 10,500 | $0.97 | $10K |
| Nov 25, 2025 | Luput CristianDirector | Buy | 10,000 | $0.98 | $10K |
| Nov 24, 2025 | Vitoc VladChief Executive Officer | Buy | 10,000 | $0.99 | $10K |
| Nov 24, 2025 | Smith StanDirector | Buy | 10,000 | $0.99 | $10K |
| Nov 21, 2025 | Vitoc VladChief Executive Officer | Buy | 1,800 | $0.92 | $2K |
| Oct 1, 2025 | Smith StanDirector | Buy | 19,230 | $1.30 | $25K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.